What are the commonly prescribed antihistamines in New Zealand?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Commonly Prescribed Antihistamines in New Zealand

In New Zealand, the commonly prescribed antihistamines include fexofenadine, loratadine, cetirizine, and desloratadine, with second-generation non-sedating antihistamines being the preferred options for most patients. 1, 2

Second-Generation Antihistamines (Preferred)

These are the first-line options due to their favorable safety profile and minimal sedative effects:

  • Fexofenadine (180mg) - Non-sedating even at higher doses, no performance impairment 1, 2, 3
  • Loratadine (10mg) - Non-sedating at recommended doses 1, 2
  • Desloratadine - Non-sedating at recommended doses 1
  • Cetirizine (10mg) - Mildly sedating, may cause drowsiness in some patients 1, 2

First-Generation Antihistamines (Limited Use)

These are used less frequently due to their sedative and anticholinergic effects:

  • Chlorphenamine (chlorpheniramine) - Sedating, used primarily for acute allergic reactions or when sedation is desired 1
  • Hydroxyzine - Highly sedating, typically reserved for nighttime use or short-term treatment 1
  • Diphenhydramine - Sedating, used primarily for sleep or acute allergic reactions 2

Clinical Decision-Making Algorithm

  1. For most patients with allergic conditions:

    • Start with a second-generation antihistamine (fexofenadine, loratadine)
    • These provide effective symptom control with minimal sedation 1, 3
  2. For elderly patients:

    • Avoid first-generation antihistamines due to increased risk of falls, cognitive impairment, and anticholinergic effects 1
    • Use fexofenadine or loratadine at standard doses 1
  3. For patients with daytime symptoms requiring alertness:

    • Use fexofenadine (preferred) or loratadine 1, 3
    • Avoid cetirizine if sedation is a concern 1
  4. For patients with nighttime symptoms or sleep disturbance:

    • Consider adding a first-generation antihistamine at night only 1
    • Example: daytime non-sedating + nighttime sedating antihistamine
  5. For refractory symptoms:

    • Increase dose of second-generation antihistamine up to 4 times the standard dose 2
    • Consider combination therapy with H2 antagonists (e.g., cimetidine) 1, 2

Important Clinical Considerations

  • Sedation risk: First-generation antihistamines significantly impair cognitive function, driving ability, and work performance 1, 3, 4

  • Dosing adjustments: Reduce doses in renal impairment, particularly for cetirizine and levocetirizine 1

  • Pregnancy considerations: Avoid all antihistamines if possible, especially in the first trimester; chlorphenamine has the longest safety record if treatment is necessary 1

  • Pediatric use: Second-generation antihistamines are generally safe for children over 12 years; consult product information for younger children 1, 5

  • Drug interactions: Second-generation antihistamines have fewer drug interactions than first-generation options 6

Common Pitfalls to Avoid

  1. Prescribing first-generation antihistamines for daytime use - These cause significant sedation and impair performance, even when patients don't feel drowsy 1, 4

  2. Prescribing sedating antihistamines to elderly patients - This increases fall risk and can worsen cognitive function 1

  3. Assuming all second-generation antihistamines are equally non-sedating - Cetirizine has more sedative potential than fexofenadine or loratadine 1, 3

  4. Underdosing in refractory cases - For difficult-to-control symptoms, increasing the dose of second-generation antihistamines (up to 4x standard dose) may be more effective than adding other medications 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Urticaria Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Safety of second generation antihistamines.

Allergy and asthma proceedings, 2000

Research

First do no harm: managing antihistamine impairment in patients with allergic rhinitis.

The Journal of allergy and clinical immunology, 2003

Research

Antihistamines: ABC for the pediatricians.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2020

Research

Histamine, histamine receptors and antihistamines: new concepts.

Anais brasileiros de dermatologia, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.